Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seyed Moayed Alavian

Showing results (41-50 of 327) with videos related to

Pageof 33
Sort By:
Hepatitis Monthly|March 6, 2015
Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1Heidar Sharafi, Seyed Moayed Alavian, Maryam Keshvari
European Journal of Clinical Pharmacology|September 22, 2010
Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysisSeyed-Moayed Alavian, Bita Behnava, Seyed Vahid Tabatabaei
Journal of Virus Eradication|March 24, 2018
Art and viral hepatitis elimination programmesMaryam Nima, Hamidreza Karimi-Sari, Seyed Moayed Alavian
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 12, 2010
Implementing strategies for hepatitis B vaccinationSeyed Moayed Alavian, Farahnaz Fallahian, Kamran Bagheri Lankarani
Hepatitis Monthly|February 8, 2012
Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infectionMahmoud Aboelneen Khattab, Mohammed Eslam, Seyed Moayed Alavian
Hepatitis Monthly|February 8, 2012
The comparative efficacy and safety of peginterferon alpha-2a vs. 2b for the treatment of chronic HCV infection: a meta-analysisSeyed Moayed Alavian, Bita Behnava, Seyed Vahid Tabatabaei
Gastroenterology and Hepatology From Bed to Bench|September 19, 2019
Investigating the impact of eight weeks of aerobic and resistance training on blood lipid profile in elderly with non-alcoholic fatty liver disease: a randomized clinical trialMohammad Ebrahim Ghamarchehreh, Alireza Shamsoddini, Seyed Moayed Alavian
Journal of Gastrointestinal and Liver Diseases : JGLD|January 15, 2008
The changing epidemiology of viral hepatitis B in IranSeyed Moayed Alavian, Farahnaz Fallahian, Kamran Bagheri Lankarani
Clinical Chemistry and Laboratory Medicine|September 20, 2018
Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic reviewSeyyed Mortaza Haghgoo, Heidar Sharafi, Seyed Moayed Alavian
Hepatitis Monthly|May 3, 2012
Hepatitis B immune globulin in liver transplantation prophylaxis: an updatePayam Dindoost, Seyed Mohammad Jazayeri, Seyed Moayed Alavian
Pageof 33

Showing results (41-50 of 327) with videos related to

Sort By:
Pageof 33
Hepatitis Monthly|March 6, 2015
Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1Heidar Sharafi, Seyed Moayed Alavian, Maryam Keshvari
European Journal of Clinical Pharmacology|September 22, 2010
Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysisSeyed-Moayed Alavian, Bita Behnava, Seyed Vahid Tabatabaei
Journal of Virus Eradication|March 24, 2018
Art and viral hepatitis elimination programmesMaryam Nima, Hamidreza Karimi-Sari, Seyed Moayed Alavian
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 12, 2010
Implementing strategies for hepatitis B vaccinationSeyed Moayed Alavian, Farahnaz Fallahian, Kamran Bagheri Lankarani
Hepatitis Monthly|February 8, 2012
Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infectionMahmoud Aboelneen Khattab, Mohammed Eslam, Seyed Moayed Alavian
Hepatitis Monthly|February 8, 2012
The comparative efficacy and safety of peginterferon alpha-2a vs. 2b for the treatment of chronic HCV infection: a meta-analysisSeyed Moayed Alavian, Bita Behnava, Seyed Vahid Tabatabaei
Gastroenterology and Hepatology From Bed to Bench|September 19, 2019
Investigating the impact of eight weeks of aerobic and resistance training on blood lipid profile in elderly with non-alcoholic fatty liver disease: a randomized clinical trialMohammad Ebrahim Ghamarchehreh, Alireza Shamsoddini, Seyed Moayed Alavian
Journal of Gastrointestinal and Liver Diseases : JGLD|January 15, 2008
The changing epidemiology of viral hepatitis B in IranSeyed Moayed Alavian, Farahnaz Fallahian, Kamran Bagheri Lankarani
Clinical Chemistry and Laboratory Medicine|September 20, 2018
Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic reviewSeyyed Mortaza Haghgoo, Heidar Sharafi, Seyed Moayed Alavian
Hepatitis Monthly|May 3, 2012
Hepatitis B immune globulin in liver transplantation prophylaxis: an updatePayam Dindoost, Seyed Mohammad Jazayeri, Seyed Moayed Alavian
Pageof 33